Metabolic and inflammatory profiles of biomarkers in obesity, metabolic syndrome, and diabetes in a mediterranean population. DARIOS inflammatory study;Perfil metabólico-inflamatorio en la transición obesidad, síndrome metabólico y diabetes mellitus en población mediterránea. Estudio DARIOS Inflamatorio

Revista Espanola de Cardiologia

Volumn 67, Issue 8, 2014, Pages 624-631

  Fernández Bergés, Daniel ^a,b   Consuegra Sánchez, Luciano ^a,c   Peñafiel, Judith ^d   Cabrera De León, Antonio ^e,f   Vila, Joan ^d,g   Félix Redondo, Francisco Javier ^a,h   Segura Fragoso, Antonio ⁱ   Lapetra, José ^j,k   Guembe, María Jesús ^l,m   Vega, Tomás ⁿ   Fitó, Montse ^d,k   Elosua, Roberto ^d   Díaz, Oscar ^d,o   Marrugat, Jaume ^d  

^a Programa de Investigación Cardiovascular PERICLES   (Spain)

^b HOSPITAL DON BENITO VILLANUEVA   (Spain)

^c Hospital Universitario de Santa Lucia   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^f UNIVERSIDAD DE LA LAGUNA   (Spain)

^g CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^h Centro de Salud Villanueva Norte   (Spain)

ⁱ Servicio de Laboratorio   (Spain)

^j Servicio Andaluz de Salud   (Spain)

^k Instituto de Salud Carlos III   (Spain)

^l Unidad de Evaluación   (Spain)

^m Grupo de Investigación Riesgo Vascular en Navarra RIVANA   (Spain)

ⁿ Departamento de Salud Pública   (Spain)

^o UNIVERSITAT POMPEU FABRA   (Spain)

more..

Author keywords

Biomarkers; Diabetes mellitus; Metabolic syndrome; Obesity

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBOHYDRATE; INSULIN; LEPTIN; LIPID;

ADULT; ARTICLE; BLOOD CLOTTING; BODY MASS; BODY WEIGHT; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HEART MUSCLE INJURY; HEMODYNAMICS; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; OXIDATION; PHENOTYPE; PROTEIN BLOOD LEVEL; RISK FACTOR; SOUTHERN EUROPE; BLOOD; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 2; METABOLISM; MULTICENTER STUDY; PREVALENCE;

BIOMARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFLAMMATION; MALE; MEDITERRANEAN REGION; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS;

EID: 84904722832     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2013.10.021     Document Type: Article

References (47)

1. I.R. Dégano, R. Elosua, J.C. Kaski, D.J. Fernández- Bergés, M. Grau, and J. Marrugat Estabilidad de la placa aterosclerótica y la paradoja del sur de Europa Rev Esp Cardiol 66 2013 56 62
2. Instituto Nacional de Estadística. INEbase: Operaciones estadísticas: clasificación por temas [cited 2013 Jul 23]. Available at: http://www.ine.es/inebmenu/indice.htm.
3. F.J. Félix-Redondo, M. Grau, J.M. Baena-Díez, I.R. Dégano, A.C. De León, and M.J. Guembe et al. Prevalence of obesity and associated cardiovascular risk: the DARIOS study BMC Public Health 13 2013 542
4. D. Fernández-Bergés, A. Cabrera de León, H. Sanz, R. Elosua, M.J. Guembe, and M. Alzamora et al. Síndrome metabólico en España: prevalencia y riesgo coronario asociado con la definición armonizada y la OMS Estudio DARIOS. Rev Esp Cardiol 65 2012 241 248
5. M. Grau, R. Elosua, A. Cabrera de León, M.J. Guembe, J.M. Baena-Diez, and T. Vega Alonso et al. Factores de riesgo cardiovascular en España en la primera década del siglo xxi: análisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS Rev Esp Cardiol 64 2011 295 304
6. C.L. Ogden, M.D. Carroll, L.R. Curtin, M.A. McDowell, C.J. Tabak, and K.M. Flegal Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 2006 1549 1555
7. G.R. Hajer, T.W. Van Haeften, and F.L. Visseren Adipose tissue dysfunction in obesity, diabetes and vascular diseases Eur Heart J 29 2008 2959 2971
8. R.H. Unger, and P.E. Scherer Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity Trends Endocrinol Metab 21 2010 345 352
9. F. Emanuela, M. Grazia, D.R. Marco, L. Maria Paola, F. Giorgio, and B. Marco Inflammation as a link between obesity and metabolic syndrome J Nutr Metab 2012 2012:476380
10. B.B. Duncan, M.I. Schmidt, J.S. Pankow, C.M. Ballantyne, D. Couper, and A. Vigo et al. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities study. 52 2003 1799 1805
11. A. Cabrera de León, M.C. Rodríguez Pérez, D. Almeida González, S. Domínguez Coello, A. Aguirre Jaime, and B. Brito Díaz et al. Presentación de la cohorte «CDC de Canarias»: objetivos, diseño y resultados preliminares Rev Esp Salud Pública 82 2008 519 534
12. J.M. Santos, V. Urbano, E. Mayoral, C. Lama, M.A. Ramos, and L. Lahera et al. Prevalence of the metabolic syndrome in Andalusian population according to the definitions of ATPIII and International Diabetes Federation Obes Metab 5 Suppl 1 2009 38
13. F.J. Félix-Redondo, D. Fernández-Bergés, J.F. Pérez, M.J. Zaro, A. García, and L. Lozano et al. Prevalencia, detección, tratamiento y grado de control de los factores de riesgo cardiovascular en la población de Extremadura (España). Estudio HERMEX Aten Primaria 43 2011 426 434
14. A.T. Vega Alonso, J.E. Lozano Alonso, R. Álamo Sanz, S. Lleras Muñoz, A. Escribano Hernández, and P. De la Iglesia Rodríguez Diseño de un estudio poblacional del riesgo cardiovascular en Castilla y León a través de los equipos de atención primaria Gac Sanit 21 2007 84 87
15. M. Grau, I. Subirana, R. Elosua, P. Solanas, R. Ramos, and R. Masiá et al. Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain Eur J Cardiovasc Prev Rehabil 14 2007 653 659
16. J.J. Viñes, J. Díez, M.J. Guembe, P. González, C. Amézqueta, and J. Barba et al. Estudio de riesgo vascular en Navarra: objetivos y diseño. Prevalencia del síndrome metabólico y de los factores mayores de riesgo vascular An Sist Sanit Navar 30 2007 113 124
17. A. Segura Fragoso, and G. Rius Mery Factores de riesgo cardiovascular en una población rural de Castilla-La Mancha Rev Esp Cardiol 52 1999 577 588
18. Manual of The MONICA Project [cited 2013 Abr 3]. Geneva: World Health Organisation; 2000. Available at: http://www.ktl.fi/publications/monica/manual/ index.htm
19. Consenso SEEDO'2000 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica Med Clin (Barc) 115 2000 587 597
20. S.M. Grundy, H.B. Brewer Jr., J.I. Cleeman, S.C. Smith Jr., and C. Lenfant American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438
21. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, and K.A. Donato et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
22. T. Suganami, and Y. Ogawa Adipose tissue macrophages: their role in adipose tissue remodeling J Leukoc Biol 88 2010 33 39
23. T. Nomiyama, D. Perez-Tilve, D. Ogawa, F. Gizard, Y. Zhao, and E.B. Heywood et al. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice J Clin Invest 117 2007 2877 2888
24. N. Hosogai, A. Fukuhara, K. Oshima, Y. Miyata, S. Tanaka, and K. Segawa et al. Adipose tissue hipoxia in obesity and its impact on adipocytokine dysregulation Diabetes 56 2007 901 911
25. S. Schenk, M. Saberi, and J.M. Olefsky Insulin sensitivity: modulation by nutrients and inflammation J Clin Invest 118 2008 2992 3002
26. A.H. Berg, and P.E. Scherer Adipose tissue, inflammation and cardiovascular disease Circ Res 96 2005 939 949
27. I.S. Okosun, Y. Liao, C.N. Rotimi, T.E. Prewitt, and R.S. Cooper Abdominal adiposity and clustering of multiple metabolic syndrome in white, black and hispanic Americans Ann Epidemiol 10 2000 263 270
28. C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC) F. Wensley, P. Gao, S. Burgess, S. Kaptoge, E. Di Angelantonio, and T. Shah et al. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data BMJ 342 2011 d548
29. T. Kadowaki, and T. Yamauchi Adiponectin and adiponectin receptors Endocr Rev 26 2005 439 451
30. S. Fischer, M. Hanefeld, S.M. Haffner, C. Fusch, U. Schwanebeck, and C. Kohler et al. Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass Acta Diabetol. 39 2002 105 110
31. N. Ouchi, S. Kihara, T. Funahashi, T. Nakamura, M. Nishida, and M. Jumada et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue Circulation 107 2003 671 674
32. D.M. Lloyd-Jones, K. Liu, L. Tian, and P. Greenland Narrative review: assesment of C-reactive protein in risk prediction for cardiovascular disease Ann Intern Med 145 2006 35 42
33. K. Chen, F. Li, H. Cai, S. Strom, A. Bisello, and D.E. Kelley et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin Nat Med 12 2006 425 432
34. W.L. Hutchinson, A.P. Coll, J.R. Gallimore, G.A. Tennent, and M.B. Pepys Is leptin an important physiological regulator of CRP? Nat Med 13 2007 17 18
35. C. Finelli, and G. Tarantino What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J Gastroenterol 19 2013 802 812
36. S.H. Han, M.J. Quon, J.A. Kim, and K.K. Koh Adiponectin and cardiovascular disease J Am Coll Cardiol 49 2007 531 538
37. B.B. Duncan, M.I. Schmidt, J.S. Pankow, H. Bang, D. Couper, and C.M. Ballantyne et al. Adiponectin and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study Diabetes 53 2004 2473 2478
38. J. Krakoff, T. Funahashi, C.D. Stehouwer, C.G. Schalkwijk, S. Tanaka, and Y. Matsuzawa et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian Diabetes Care 26 2003 1745 1751
39. K. Matsushita, H. Yatsuya, K. Tamakoshi, K. Wada, R. Otsuka, and S. Takefuji et al. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men Arterioscler Thromb Vasc Biol 26 2006 871 876
40. M. Kumada, S. Kihara, S. Sumitsuji, T. Kawamoto, and S. Matsumoto Association of hypoadiponectinemia with coronary artery disease in men Arterioscler Thromb Vasc Biol 23 2003 85 89
41. T. Pischon, C.J. Girman, G.S. Hotamisligil, N. Rifai, F.B. Hu, and E.B. Rimm Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730 1737
42. A.D. Karelis Metabolically healthy but obese individuals Lancet 372 2008 1281 1283
43. M.W. Schwartaz, S.C. Woods, D. Porte Jr., R.J. Seeley, and D.G. Baskin Central nervous system control of food intake Nature 404 2000 661 671
44. C. Li, E.S. Ford, Y.X. Meng, A.H. Mokdad, and G.M. Reaven Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovasc Diabetol 7 2008 4 10.1186/1475-2840-7-4
45. A. Cabrera de León, S. Domínguez Coello, D. Almeida González, B. Brito Díaz, J.C. Del Castillo Rodríguez, and A. González Hernández et al. Impaired fasting glucose, ancestry and waist-to-height ratio: main predictors of diabetes in the Canary Islands Diabet Med 29 2012 399 403
46. G. Walldius, I. Jungner, A.H. Aastveil, I. Holme, C.D. Furberg, and A.D. Sniderman The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk Clin Chem Lab Med 42 2004 1355 1363
47. M. Ashwell, P. Gunn, and S. Gibson Waist to height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systemic review and meta-analysis Obes Rev 13 2012 275 286